[Registration Open] Online Public Symposium “Dementia Risk Reduction: How Society Should Face the Individualization of Risk” (December 12, 2023)
date : 10/31/2023
Tags: Dementia
![[Registration Open] Online Public Symposium “Dementia Risk Reduction: How Society Should Face the Individualization of Risk” (December 12, 2023)](https://hgpi.org/en/wp-content/uploads/sites/2/dementia-20231212-top-1.png)
As Japan becomes a super-aging nation, the topic of dementia risk reduction is attracting great attention from society. The National Framework for Promotion of Dementia Policies approved by Cabinet decision in June 2019 states that inclusion and prevention are to be advanced in parallel. Research on dementia risk factors is now progressing and various activities like exercise and social participation are being expanded. Article 21 of the Basic Policies of the Dementia Basic Act for an Inclusive Society (or, the “Dementia Basic Act”) enacted in June 2023 also included, “Implement policies needed to enable willing participants to engage in appropriate and scientifically sound activities for dementia and mild cognitive impairment.”
People often misinterpret “dementia prevention” to mean “not developing dementia”, but Japanese policy documents, for example, divide it into three categories: primary prevention (delaying onset), secondary prevention (early detection, diagnosis, and intervention), and tertiary prevention (preventing severe complications, maintaining function, and responding to BPSD). Although prevention spans a very long period of time, each of its phases is related, meaning “dementia prevention” requires a seamless response. For example, while paying careful attention to delaying onset, one must be ready to quickly transition to the phase for early detection, diagnosis, and intervention.
Methods of approaching dementia risk are beginning to transform to require earlier responses with greater emphasis on actions taken on the individual level. This is an ongoing trend in Japan and around the world, and it is safe to say that it will be an inevitable part of future developments in medicine. This symposium will be an opportunity to consider how civil society should respond to the individualization of risk and what actions should be taken by society as a whole. We will introduce the latest studies and initiatives for dementia risk, including examples from overseas, as well as share methods of approaching risks with society from the perspectives of industry, government, academia, and civil society. We will also consider how to best develop public-private partnerships and utilize private sector solutions. Finally, from the perspective of dementia, we will deepen discussions on how to best structure financial resources and the burdens associated with measures for prevention and health promotion.
[Event Overview]
- Date and Time: Tuesday, December 12, 2023; 17:00 – 20:30 JST
- Format: Online (Zoom Webinars); the lecture archive will be available at a later date
- Language: Japanese and English, with simultaneous interpretation
- Participation fee: Free
- Host: Health and Global Policy Institute
- Sponsor:
Integra LifeSciences Corporation.
Splink,Inc.
Sompo Holdings, Inc.
National Graduate Institute for Policy Studies (GRIPS) Global Health Innovation Policy Program (GHIPP)
[Programme] (Titles omitted; in Japanese syllabary order)
17:00-17:05 | Opening remarks |
Hayato Suzuki (Member, House of Representatives / Executive Director, Parliamentary Association for Promoting Dementia Policies for an Inclusive Society) |
|
17:05-17:10 | Explanatory introduction |
Shunichiro Kurita (Senior Manager, HGPI) | |
Part1 | |
17:10-17:35 | Keynote lecture: Ethical Issues on the Individualization of Dementia Risk |
Shingo Segawa (Project coordinator and Researcher, Department of Medical Ethics and History of Medicine, University Medical Center Göttingen) | |
17:35-18:05 | Presentations: The Frontlines of Dementia Risk |
Building Evidence through Multifactorial Interventions Developing Communities to Foster Longevity |
|
Part 2 | |
18:10-19:20 | Presentations: Preparing for Dementia Risk as a Society |
From the perspective of industry: Necessary Steps to Develop Brain Health From the perspective of industry: Building and Providing a Comprehensive Support Package From the perspective of academia: Preventing Severe Complications Using Robots and Industry-Academia Collaboration From the perspective of academia: Transitioning from Individual Disease Prevention to Community-Building From the perspective of academia: A Form of Dementia that Improves with Treatment and Building Early Detection System From the perspective of civil society: Civil Society-Led Action to Prepare as a Society From the perspective of government: Improving Dementia in the *Me-Byo Stage |
|
19:20-19:30 | Recess |
19:30-20:30 | Discussion: How to Bear the Costs of Prevention and Health Promotion as a Society |
Panelists: Moderator: |
Top Research & Recommendations Posts
- [Announcement] HGPI Joins Call for “Global Health and Medical Community Unite To Demand End Fossil Fuel Dependency at COP28” (November 1, 2023)
- [Research Paper] “Rethinking Japan’s Health System Sustainability Under the Planetary Health Framework” Published in Health Systems & Reform (November 21, 2023)
- [Research Report] The Public Opinion Survey on Child-Rearing in Modern Japan (Final Report) (March 4, 2022)
- [Policy Recommendations] Furthering the Development of Precision Cancer Medicine —Proposals for Effective Policy Changes Based on Key Characteristics of Precision Medicine in Cancer Treatment— (September 20, 2022)
- [Activity Report] HGPI Submits Requests for the G7 Hiroshima Summit to the G7 Sous-Sherpa (December 23, 2022)
- [Urgent Recommendations] The Kidney Disease Control Promotion Project – Establishing Kidney Disease Control Measures with Patient, Citizen, and Community Engagement and Collaboration: Recommendations for Current Issues and Topics in Kidney Disease Control (May 11, 2022)
- [Case Study] Akari Shigemi “The importance of proper antimicrobial use for MRSA infections – Beware of rifampicin monotherapy induced resistance” (AMR Alliance Japan, December 22, 2021)
- [Research Report] Survey of Japanese Physicians Regarding Climate Change and Health (December 3, 2023)
- [Recommendations] The Future of Dementia Policy 2022: Deepening Dementia Policies Centered on People Living with Dementia and their Families to Lead Global Society (July 13, 2022)
- [Announcement] HGPI Declares the Ministry of the Environment-led ‘Deco-Katsu Declaration’ and Participation in the ‘Deco-Katsu’ Supporters (October 16, 2023)
Featured Posts
-
2023-10-31
[Registration Open] Online Public Symposium “Dementia Risk Reduction: How Society Should Face the Individualization of Risk” (December 12, 2023)
-
2023-11-27
[Registration Open] (Webinar) HGPI Cooperation with Lancet Countdown 2023 Japan Presentation “Climate Change as a Children’s Health Issue: The Latest Lancet Report Sounds the Alarm for Health Commitments” (December 14, 2023)
-
2023-11-28
[Event Report] The 1st Advisory Board Meeting for Patient and Public Involvement (PPI) Support Project “Necessary Steps for Promoting PPI in Policy Making” (October 3, 2023)
-
2023-11-29
[Policy Recommendations] Coming Together to Protect and Foster: Promoting Innovative and Sustainable Planetary Health in the Asia-Pacific Region to Build Resilient Health Systems (November 29, 2023)
-
2023-11-30
[Announcement] HGPI Endorsed “For the Health of People and Planet: Priorities for a Healthy COP28” (November 30, 2023)